THURSDAY, DECEMBER 8, 2016

Study shows effectiveness of new HIV therapy drugs on infected children

Louise Kuhn, a professor of epidemiology at Columbia University's Mailman School of Public Health, has been studying the effects of switching HIV therapy drugs after achieving viral suppression. Read More »

Patient files to block patents for two HIV drugs

Doctors Without Borders (MSF) and an HIV patient in India recently filed an application to block ViiV Healthcare from receiving patents for two new important HIV drugs. Read More »

Nigerian officials conduct door-to-door visits to manage polio

Health care workers in Nigeria are conducting door-to-door visits among local residents to ensure Nigerians have received their polio vaccinations, as health professionals believe this will manage the disease's spread. Read More »

Use of Option B+ therapy shows reduction of maternal transmission of HIV

Columbia University researchers conducted a study in Swaziland to find that applying Option B+ has helped increase the amount of women who begin antiretroviral therapy (ART) for HIV infections. Read More »

ViiV Healthcare purchases HIV R&D portfolio from Bristol-Myers Squibb

ViiV Healthcare recently finalized its acquisition of a portfolio with HIV research and development information from Bristol-Myers Squibb. Read More »

Global Fund, UN alliance progresses toward malaria elimination

The Global Fund and the U.N. Development Program in Principe and São Tomé recently agreed to continue work toward eliminating malaria. Read More »

Red Cross volunteers prepare Ebola-stricken communities for future emergencies

Tadateru Konoé, the president of the International Federation of Red Cross and Red Crescent Societies (IFRC), recently encouraged the nations impacted by Ebola to acknowledge how Red Cross volunteers have improved local communities to prepare for future emergencies. Read More »

Many TB tests inaccurate for pregnant women with HIV

Many of the tests that are most commonly used to diagnose tuberculosis may be inaccurate for diagnosing approximately 50 percent of pregnant women who have HIV infections. Read More »

Buffalo study evaluates U.S. public's response to Ebola outbreak

Researchers from the University of Buffalo recently conducted a study to evaluate the role of risk communication and altruism of the U.S. public during the Ebola outbreak in West Africa. Read More »

Experimental immunotherapy eliminates deadliest Ebola strains

Scientists from Albert Einstein College of Medicine and the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID)  recently developed an experimental immunotherapy with antibodies that effectively eliminates the two most lethal Ebola strains. Read More »

Doctors Without Borders launches vaccine campaign in Africa

Health care workers from Doctors Without Borders (MSF) recently launched a vaccine campaign in the Central African Republic (CAR) on a scale that has never been seen before. Read More »

Antimalarial drug decreases mortality rate among Ebola patients

A recent study published in the New England Journal of Medicine by Doctors Without Borders (MSF) and Epicentre, MSF’s research branch, shows that an antimalarial drug may decrease mortality among Ebola patients. Read More »

NYU study shows minor influenza strains pose significant threats

New York University scientists recently discovered that even minor influenza strains can still have a significant impact and create notable health threats to the public. Read More »

Officials in Congo report 474 deaths from measles

Congo's Ministry of Public Health recently released an update about the measles epidemic that has been taking place since the start of 2015. Read More »

Study reveals Ebola, bats wage molecular war

A recent study from the University of Colorado-Boulder, Albert Einstein College of Medicine, and the U.S. Army Medical Research Institute of Infectious Diseases has demonstrated that the Ebola virus and bats have fought a molecular war for centuries Read More »

Study reports limited access to sterile needle programs in US

A recent study from the Icahn School of Medicine at Mount Sinai shows there is limited accessibility to harm-reduction services and programs in areas that have higher rates of intravenous drug use and HIV infections. Read More »

New York Blood Center scientists receive medical patents

Scientists from the New York Blood Center (NYBC) have received patents for several projects that are designed to safeguard the U.S. blood supply and advance vaccine therapies. Read More »

Exposure to toxic chemicals correlates with limited vaccine response

Scientists from the University of Rochester (UR) Environmental Health Sciences Center recently conducted a study that suggests having toxic chemical exposure in early life can inhibit a baby’s vaccine response. Read More »

Study shows risky sex more likely in young men with HIV

Scientists at Columbia University's Mailman School of Public Health recently conducted a study that shows young men who have detectable HIV are much more likely to engage in risky sexual acts than young men who have attained virological suppression. Read More »

Outdated practices stall drug-resistant TB fight

Leaders from Doctors Without Borders (MSF) and the Stop TB Partnership recently published the second part of the report titled "Out of Step," which was previously an outdated resource that allowed drug-resistant tuberculosis (TB) to continue spreading. Read More »